Company
Vernal Biosciences
Integrated CDMO services for mRNA and LNP
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Colchester, Vermont, United States
- Customers
- drug developers
Claim, correct or request removal
Record updated 28 September 2026
About
Vernal Biosciences is a leading mRNA CDMO, providing fast, reliable access to high-purity mRNA, LNP-mRNA, and full-spectrum services including process development, GMP manufacturing, and analytical testing.
Funding snapshot
- Total raised
- $42.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $41M2022-05-10
Funding rounds
- Round, 2022
- $41M2022-05-10, SEC form D sold, 10 investors
- Round, 2021
- $1.5M2021-04-06, SEC form D sold, 9 investors
Loading relationship preview